Rahel Heule1,2, Raimund Kottke3, and Ruth Tuura1,2
1Center for MR Research, University Children's Hospital, Zurich, Switzerland, 2Children's Research Center, University Children's Hospital, University of Zurich, Zurich, Switzerland, 3Department of Diagnostic Imaging, University Children’s Hospital, Zurich, Switzerland
Synopsis
Keywords: Neuro, Arterial spin labelling
Delayed perfusion in patients
with Moyamoya vasculopathy can lead to a bias in CBF quantification, especially
for single-delay ASL acquisitions. In this work, we investigate the clinical
utility of arterial transit time corrected CBF derived from a 7-delay prototype
ASL sequence for assessment of hemodynamically mediated perfusion failure in
pediatric Moyamoya patients. The multi-delay ASL acquisition proved successful
in capturing the whole distribution of transit times in the investigated
patient cohort and may thus be a valid contrast agent-free alternative to DSC-enhanced
perfusion imaging.
Introduction
Moyamoya vasculopathy, characterized
by progressive stenosis of the internal carotid arteries, most commonly presents
with recurrent transient ischemic attacks and stroke in childhood due to
hemodynamically mediated perfusion failure. Identification of abnormal tissue
perfusion in children with Moyamoya syndrome or disease is essential for early treatment
planning including surgical cerebral revascularization to increase the blood
supply in hypoperfused vascular territories (1). Arterial spin labeling (ASL) allows for cerebral
blood flow (CBF) assessment without the need for contrast agents as opposed to dynamic
susceptibility contrast (DSC)-enhanced perfusion imaging, which relies on bolus
tracking after intravenous injection of a gadolinium-based contrast agent. However,
delayed perfusion due to vessel occlusion in Moyamoya patients can lead to an underestimation
of CBF with conventional single-delay ASL, which favors multi-delay
acquisitions. Here, we investigate the influence of arterial transit time (ATT)
distribution in children with Moyamoya vasculopathy
on the clinical utility of single-delay versus multi-delay pseudo-continuous arterial
spin labeling (pCASL) using a recently introduced template consisting of five
bilateral vascular territories (2).Methods
Patient cohort and MR protocol
We analyzed the cerebral
perfusion imaging data of fourteen children and adolescents with Moyamoya syndrome
or disease (5 females; median age: 11 years, age range: 3 – 18 years), who
underwent MR examinations at either 1.5 T (SIGNA Artist, GE Healthcare; 4
patients) or 3 T (DISCOVERY MR750 or SIGNA Premier, GE Healthcare; 10 patients).
The MR protocol relevant for this analysis included:
-
a T2-weighted fast recovery fast spin-echo
(FRFSE) sequence for anatomical reference and segmentation purposes
-
a standard 3D pCASL acquisition with spiral readout
using a single post-label delay (PLD) of 1525 ms and a label duration of 1450
ms
-
a time-encoded 7-delay 3D pCASL prototype sequence with
spiral readout termed enhanced ASL (eASL) using PLDs in the range [1000, 3582]
ms / [1000, 3658] ms with corresponding effective label durations in the range
[348, 918] ms / [361, 842] ms, calculated by assuming arterial blood T1
values of 1400 ms / 1650 ms, at 1.5 T / 3 T
-
DSC perfusion-weighted scans using a gradient-echo
echo-planar imaging (EPI) sequence with an intravenous bolus injection of
gadolinium contrast agent
CBF and transit time analysis
We compared the following
perfusion data with respect to potential transit time impairments:
-
CBFstd: CBF maps of the standard
single-delay ASL measurement, which were obtained by assuming that the arterial
transit time is less than or equal to the employed PLD of 1525 ms
-
CBFav: CBF maps calculated based on the
average perfusion-weighted signal from the multi-delay eASL measurement and
thus not transit time-corrected
-
ATT, CBFcorr: The employed multi-delay
eASL acquisition enables to probe for bolus arrival time and to calculate signal-weighted
delays, which can be converted into ATT maps (3). These ATT values were
then used to obtain transit time-corrected CBF maps.
-
rCBF: relative CBF maps obtained by deconvolution
of the motion-corrected DSC image series with the arterial input function
The T
2-weighted brain template in
MNI space was registered to the perfusion data via the acquired native T
2-weighted
data and the same transformation was applied to the vascular territory atlas
(cf. Fig. 1). Five bilateral territories (anterior cerebral artery, ACA; middle
cerebral artery, MCA; posterior cerebral artery, PCA; pons/medulla; cerebellum)
were identified in the full-brain vascular territory map (2) as illustrated in
Figure 1 and used to calculate mean territory-based perfusion values.
Results
As can be seen from
Figure 2, the transit corrected CBFcorr is highly correlated with
the CBFav derived based on the same acquisition (r >= 0.94) as
well as with CBFstd obtained from the standard single-delay acquisition
(r >= 0.88). The linear relationship is driven by a transit time bias
inherent to CBFav and CBFstd as evidenced in Figure 3 by
a high correlation in case of CBFav (r >= 0.98) and a moderate
correlation in case of CBFstd (r >= 0.46) between the transit
time and the deviation of CBFav and CBFstd, respectively,
from CBFcorr. This implies an underestimation of uncorrected CBF for
transit times longer than PLD (cf. Fig. 4), which may become relevant for
delayed perfusion in children with Moyamoya syndrome or disease. The 7-delay
ASL acquisition with a maximal PLD of 3.6 – 3.7 seconds appeared to be able to
capture the full distribution of transit times expected in children and
adolescents with Moyamoya vasculopathy (cf. Fig. 5) and no apparent transit-time
induced mismatch with the rCBF of the DSC acquisition was observed.Discussion and Conclusion
In patients with Moyamoya
vasculopathy, delayed perfusion can result in a bias in CBF quantification,
especially for single-delay protocols. This renders multi-delay ASL
acquisitions beneficial, which allow for the simultaneous quantification of ATT
and transit time corrected CBF. The investigated 7-delay ASL prototype proved
successful in capturing the whole distribution of transit times in a pediatric cohort
of fourteen Moyamoya patients. It thus appears as a valid contrast agent-free
alternative to DSC-enhanced perfusion imaging.Acknowledgements
We acknowledge support
from GE Healthcare for providing the enhanced arterial spin labeling (eASL)
prototype sequence and from David Shin (GE Healthcare) for assisting with the
interpretation of the quantitative output maps.References
1. Calamante F, Ganesan V, Kirkham FJ, Jan W, Chong WK, Gadian
DG, Connelly A. MR perfusion imaging in Moyamoya Syndrome: potential
implications for clinical evaluation of occlusive cerebrovascular disease.
Stroke 2001;32(12):2810-2816.
2. Schirmer MD, Giese AK, Fotiadis P, Etherton MR, Cloonan L,
Viswanathan A, Greenberg SM, Wu O, Rost NS. Spatial Signature of White Matter
Hyperintensities in Stroke Patients. Front Neurol 2019;10:208.
3. Dai W, Robson PM, Shankaranarayanan A, Alsop DC. Reduced
resolution transit delay prescan for quantitative continuous arterial spin
labeling perfusion imaging. Magn Reson Med 2012;67(5):1252-1265.